Clinical porcine islet xenotransplantation under comprehensive regulation

Transplantation Proceedings

Volumn 46, Issue 6, 2014, Pages 1992-1995

  Matsumoto, S ^a   Tan, P ^b   Baker, J ^c   Durbin, K ^b   Tomiya, M ^a   Azuma, K ^a   Doi, M ^a   Elliott, R B ^b  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^b Living Cell Technologies Ltd   (New Zealand)

^c MIDDLEMORE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; BODY MASS; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONFERENCE PAPER; CONTROLLED STUDY; DEPRESSION; DNA VIRUS; ENCAPSULATION; ENDOGENOUS RETROVIRUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERSENSITIVITY; HYPOGLYCEMIA; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LAPAROSCOPY; MALE; MOUSE; NEW ZEALAND; NEWBORN; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PANCREAS ISLET TRANSPLANTATION; PERITONEAL CAVITY; PRIORITY JOURNAL; RNA VIRUS; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRANSPLANT ESTIMATED FUNCTION; XENOTRANSPLANTATION; ANIMAL CELL; ANXIETY DISORDER; ARTICLE; CELL ENCAPSULATION; DISEASE DURATION; INSULIN BLOOD LEVEL; PANCREAS ISLET; PIGLET; ANIMAL; BLOOD; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; METABOLISM; MIDDLE AGED; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PIG; PROCEDURES; TREATMENT OUTCOME; XENOGRAFT;

ANIMALS; ANIMALS, NEWBORN; C-PEPTIDE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MIDDLE AGED; NEW ZEALAND; SWINE; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 84906082982     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2014.06.008     Document Type: Conference Paper

References (12)

1. S. Matsumoto Islet cell transplantation for type 1 diabetes J Diabetes 2 2010 16 22
2. E. Cozzi, M. Tallacchini, and E.B. Flanagan et al. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - chapter 1: key ethical requirements and progress toward the definition of an international regulatory framework Xenotransplantation 16 2009 203 214
3. World Health Organization Second WHO global consultation on regulatory requirements for xenotransplantation clinical trials October 17-19, 2011 Switzerland Geneva
4. O. Garkavenko, M.C. Croxosn, and M. Irgang et al. Monitoring for presence of potentially xenotic viruses in recipients of pig islet xenotransplantation J Clin Microbiol 42 2004 5353 5356
5. A.L. Hillberg, K. Kathirgamanathan, and J.B.B. Lam et al. Improving alginate-poly-L-ornithine-alginate capsule biocompatibility through genipin crosslinking J Biomed Mater Res Part B 101B 2013 258 268
6. A. Caumo, P. Maffi, and R. Nano et al. Comparative evaluation of simple indices of graft function after islet transplantation Transplantation 92 2011 815 821
7. K. Paradis, G. Langford, Z. Long XEN 111 Study Group Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue Science 285 1999 1236 1241
8. P.J. O'Connell The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - chapter 6: patient selection for pilot clinical trials of islet xenotransplantation Xenotransplantation 16 2009 249 254
9. S. Matsumoto, Y. Yamada, and T. Okitsu et al. Simple evaluation of engraftment by secretory unit of islet transplant objects (SUITO) for living donor and cadaveric donor fresh or cultured islet transplantation Transplant Proc 37 2005 3435 3437
10. M. Takita, and S. Matsumoto SUITO index for evaluation of clinical islet transplantation Cell Transplant 21 2012 1341 1347
11. M. Shimoda, T. Itoh, and S. Iwahashi et al. An effective purification method using large bottles for human pancreatic islet isolation Islets 4 2012 398 404
12. S. Matsumoto, M. Takita, and D. Chaussabel et al. Improving efficacy of clinical islet transplantation with iodixanol-based islet purification, thymoglobulin induction, and blockage of IL1-beta and TNF-alpha Cell Transplant 20 2011 1641 1647